[Results and prospects for the clinical use of hyperthermia in oncology].
Artificial controlled local and total hyperthermia combined with radio- and/or chemotherapy was used for the treatment of 1211 patients with malignant tumors of different sites. A study of the long-term results of 750 patients showed that the incorporation of hyperthermia in the schemes of combined and multimodality therapy resulted in a significant increase in the 5-year survival of the patients with melanoma, soft tissue sarcoma, breast and rectal cancer.
D001943:Breast Neoplasms / Q000628:therapy; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D006979:Hyperthermia, Induced / Q000379:methods; D007822:Laryngeal Neoplasms / Q000628:therapy; D008297:Male; D008545:Melanoma / Q000628:therapy; D009369:Neoplasms / Q000188:drug therapy / Q000401:mortality / Q000532:radiotherapy*; D011182:Postoperative Care; D011300:Preoperative Care; D012004:Rectal Neoplasms / Q000628:therapy; D012509:Sarcoma / Q000628:therapy; D012878:Skin Neoplasms / Q000628:therapy; D012983:Soft Tissue Neoplasms / Q000628:therapy
Itogi i perspektivy klinicheskogo primeneniia gipertermii v onkologii.